🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07760649
Starting soon Observational

A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke

NCT07760649 · tracked via the Priya Life Science Germany tracker
Sponsor
Neuravi Limited
Phase
Observational
Started
2026-08-10
Last updated
2026-08-12

Condition(s) studied

Ischemic Stroke

Study summary

The purpose of this study is to collect medical information to monitor the ongoing safety of the J\&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * Participant is 18 years of age or older at the time of consent * Informed Consent has been provided by the participant or the participants' legally authorized representative (LAR) * Participants with angiographic confirmation of acute ischemic stroke * A clinical decision has been made to treat the participant with an eligible Johnson \& Johnson MedTech neuro-thrombectomy device independently and prior to enrollment in the study Exclusion criteria: * Known pregnancy, as evidenced by positive pregnancy test for women of childbearing potential or breast feeding * Current involvement in an investigational (drug, device, etcetera) clinical study that may confound study endpoints. Sponsor approval is required prior to enrollment

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Universitaetsklinikum Hamburg Eppendorf Hamburg Germany
Stadtisches Klinikum Solingen gemeinnutzige GmbH Solingen Germany
University Hospital Zurich Zurich Switzerland

More Neuravi Limited trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07760649 on ClinicalTrials.gov ↗ ← All trials in Germany